Aliberti S, Goeminne PC, O’Donnell AE, Aksamit TR, Al-Jahdali H, Barker AF et al. Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations. Lancet Respir Med [Internet]. 2022;10(3):298–306. Available from: https://doi.org/10.1016/S2213-2600(21)00277-0
Choi H, Chalmers JD. Bronchiectasis: from orphan disease to precision medicine. ERS Monogr. 2023;100:150–64.
Nigro M, Laska IF, Traversi L, Simonetta E, Polverino E. Epidemiology of bronchiectasis. Eur Respir Rev. 2024;33(174):240091. https://doi.org/10.1183/16000617.0091-2024.
Article PubMed PubMed Central Google Scholar
Laska IF. Prevalence of bronchiectasis: a narrative review. Ther Adv Respir Dis [Internet]. 2025;19:1–16. Available from: https://journals.sagepub.com/doi/10.1177/17534666251390073
Flume PA, Chalmers JD, Olivier KN. Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity. Lancet. 2018;392(10150):880–90. https://doi.org/10.1016/S0140-6736(18)31767-7.
Article PubMed PubMed Central Google Scholar
Long MB, Chotirmall SH, Shteinberg M, Chalmers JD. Rev Rethinking bronchiectasis as Inflamm disease. 2024;2600(24):1–14.
Chalmers JD, Goeminne P, Aliberti S, McDonnell MJ, Lonni S, Davidson J, et al. The bronchiectasis severity index an international derivation and validation study. Am J Respir Crit Care Med. 2014;189(5):576–85.
Article PubMed PubMed Central Google Scholar
Radovanovic D, Santus P, Blasi F, Sotgiu G, D’Arcangelo F, Simonetta E, et al. A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018;145(October):120–9.
Sibila O, Stobo J, Perea L, Gao YH, Xu JF, Lind H et al. Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study. Lancet Respir Med [Internet]. 2025;Accepted. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2213260025001602
Choi H, Ryu S, Keir HR, Giam YH, Dicker AJ, Perea L et al. Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study. Am J Respir Crit Care Med [Internet]. 2023;208(11):1166–76. Available from: https://www.atsjournals.org/doi/https://doi.org/10.1164/rccm.202303-0499OC
Chalmers JD, Metersky M, Aliberti S, Morgan L, Fucile S, Lauterio M et al. Neutrophilic inflammation in bronchiectasis. Eur Respir Rev [Internet]. 2025;34(176):1–19. Available from: https://doi.org/10.1183/16000617.0179-2024
Shoemark A, Shteinberg M, De Soyza A, Haworth CS, Richardson H, Gao Y, et al. Characterization of eosinophilic bronchiectasis a European multicohort study. Am J Respir Crit Care Med. 2022;205(8):894–902.
Article CAS PubMed Google Scholar
Lonni S, Chalmers JD, Goeminne PC, McDonnell MJ, Dimakou K, De Soyza A et al. Etiology of Non–Cystic Fibrosis Bronchiectasis in Adults and Its Correlation to Disease Severity. Ann Am Thorac Soc [Internet]. 2015;12(12):1764–70. Available from: https://www.atsjournals.org/doi/https://doi.org/10.1513/AnnalsATS.201507-472OC
Chalmers JD, Elborn S, Greene CM. Basic, translational and clinical aspects of bronchiectasis in adults. Eur Respir Rev. 2023. https://doi.org/10.1183/16000617.0015-2023.
Article PubMed PubMed Central Google Scholar
Sibila O, Laserna E, Shoemark A, Perea L, Bilton D, Crichton ML, et al. Heterogeneity of treatment response in bronchiectasis clinical trials. Eur Respir J. 2022. https://doi.org/10.1183/13993003.00777-2021.
Article PubMed PubMed Central Google Scholar
De Angelis A, Artuso VA, Aliberti S, Goeminne P. Screening and impact of comorbidities in bronchiectasis: a forward-looking perspective. Ther Adv Respir Dis [Internet]. 2025;19:17534666251390086. Available from: http://www.ncbi.nlm.nih.gov/pubmed/41170702
McDonnell MJ, Aliberti S, Goeminne PC, Restrepo MI, Finch S, Pesci A et al. Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study. Lancet Respir Med [Internet]. 2016;4(12):969–79. Available from: http://www.elsevier.com/journals/the-lancet-respiratory-medicine/2213-2600%0Ahttp://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed18&NEWS=N&AN=613411066
Simonetta E, De Angelis A, Silani MS, Polelli V, Nigro M, Stainer A et al. Bronchiectasis and sinonasal diseases: a narrative review. ERJ Open Res [Internet]. 2025;11(5):01087–2024. Available from: https://publications.ersnet.org/lookup/doi/https://doi.org/10.1183/23120541.01087-2024
Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon T et al. Standardised classification of the aetiology of bronchiectasis using an objective algorithm. Eur Respir J [Internet]. 2017;50(6):1701289. Available from: https://publications.ersnet.org/lookup/doi/https://doi.org/10.1183/13993003.01289-2017
Chalmers JD, Haworth CS, Flume P, Long MB, Burgel PR, Dimakou K et al. European Respiratory Society Clinical Practice Guideline for the Management of Adult Bronchiectasis. Eur Respir J [Internet]. 2025;2501126. Available from: https://publications.ersnet.org/lookup/doi/https://doi.org/10.1183/13993003.01126-2025
Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, et al. Crohn’s disease. Nat Rev Dis Prim. 2020. https://doi.org/10.1038/s41572-020-0156-2.
Kobayashi T, Siegmund B, Le Berre C, Wei SC, Ferrante M, Shen B, et al. Ulcerative colitis. Nat Rev Dis Prim. 2020. https://doi.org/10.1038/s41572-020-0205-x.
Petronio L, Dal Buono A, Gabbiadini R, Migliorisi G, Privitera G, Ferraris M, et al. Drug development in inflammatory bowel diseases: what is next? Pharmaceuticals. 2025;18(2):1–35.
Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1982–92.
Article PubMed PubMed Central Google Scholar
Gordon H, Burisch J, Ellul P, Karmiris K, Katsanos K, Allocca M, et al. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease. J Crohn’s Colitis. 2024;18(1):1–37.
Camus P, Colby TV. The spectrum of airway involvement in inflammatory bowel disease. Clin Chest Med. 2022;43(1):141–55. https://doi.org/10.1016/j.ccm.2021.12.003.
Camus P, Colby TV. Bronchiectasis associated with inflammatory bowel disease. In: Bronchiectasis [Internet]. European Respiratory Society; 2011. Available from: http://publications.ersnet.org/lookup/doi/https://doi.org/10.1183/1025448x.10004110
Marrades P, De Angelis A, Iorfida A, Perea L, Voza A, Aliberti S, et al. Bronchiectasis and treatable traits : the journey from concept to clinical practice. Respir Med. 2026;251:108593. https://doi.org/10.1016/j.rmed.2025.108593.
Ma Y, Qiang Z, Zhou M, Zhang T, Li Z, Zhong H, et al. Prevalence of bronchiectasis in inflammatory bowel disease: a systematic review and meta-analysis. Front Med. 2024;11(November):1–19.
Lee JS, Yang B, Shin HS, Lee H, Chai HG, Choi H, et al. Increased bronchiectasis risk and related risk factors in inflammatory bowel disease: a 10-year Korean national cohort study. ERJ Open Res. 2024. https://doi.org/10.1183/23120541.00087-2024.
Article PubMed PubMed Central Google Scholar
Desai D, Patil S, Udwadia Z, Maheshwari S, Abraham P, Joshi A. Pulmonary manifestations in inflammatory bowel disease: a prospective study. Indian J Gastroenterol [Internet]. 2011;30(5):225–8. Available from: http://link.springer.com/https://doi.org/10.1007/s12664-011-0129-1
Songür N, Songür Y, Tüzün M, Doğan I, Tüzün D, Ensari A et al. Pulmonary function tests and high-resolution CT in the detection of pulmonary involvement in inflammatory bowel disease. J Clin Gastroenterol [Internet]. 2003;37(4):292–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14506385
Goeminne PC, Verschueren P, Scheers H, Dupont LJ. Safety of immunomodulatory therapy in patients with bronchiectasis associated with rheumatic disease and IBD: a retrospective and cohort analysis. 2012;367–73.
Kelly MG, Frizelle FA, Thornley PT, Beckert L, Epton M, Lynch AC. Inflammatory bowel disease and the lung: is there a link between surgery and bronchiectasis? Int J Colorectal Dis. 2006;21(8):754–7.
Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine (Baltimore) [Internet]. 1993;72(3):151–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8502168
Mahadeva R, Walsh G, Flower CDR, Shneerson JM. Clinical, physiological and radiological characteristics of pulmonary disease in patients with inflammatory bowel disease. Thorax. 1997;52(SUPPL 6):41–8.
Freund O, Bar-Shai A, Alkhazov A, Stav D, Hadad Y, Perluk TM, et al. Bronchiectasis in patients with inflammatory bowel diseases – prevalence, predictors, and clinical characteristics. Chest. 2025;168(2):317–25. https://doi.org/10.1016/j.chest.2025.03.014.
Article CAS PubMed PubMed Central Google Scholar
Ghosh S, Deshwal H, Haraf R, Raju S, Saeedan M, Bin, Sarkar P, et al. Pulmonary Manifestations of Inflammatory Bowel Disease and Treatment Strategies. CHEST Pulm. 2023;1(3):100018.
Massart A, Hunt DP. Pulmonary manifestations of inflammatory bowel disease. Am J Med. 2020;133(1):39–43.
Preotesoiu I, Alexandrescu L, Cimpineanu B, Tofolean IT, Stanciu IV, Herlo A, et al. From Gut to Lungs: The Hidden Respiratory Impacts of IBD: A Systematic Review of the Literature. Int J Mol Sci. 2025;26(18):1–20.
Chalmers JD, Polverino E, Crichton ML, Ringshausen FC, De Soyza A, Vendrell M, et al. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC). Lancet Respir Med. 2023;11(7):637–49.
Martinez-García MA, Villa C, Dobarganes Y, Girón R, Maíz L, García-Clemente M, et al. RIBRON: the Spanish online bronchiectasis registry. Characterization of the first 1912 patients. Archivos de Bronconeumología (English Edition). 2021;57(1):28–35.
Dhar R, Singh S, Talwar D, Mohan M, Tripathi SK, Swarnakar R, et al. Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry. Lancet Glob Heal. 2019;7(9):e1269–79.
Aksamit TR, O’Donnell AE, Barker A, Olivier KN, Winthrop KL, Daniels MLA, et al. Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest. 2017;151(5):982–92.
Cicchetti M, De Angelis A, Simonetta E, Gramegna A, Faverio P, Contarini M et al. Prevalence and types of treatable traits in bronchiectasis: a multicentre, cross-sectional study. ERJ Open Res [Internet]. 2025;Accepted:00670–2025. Available from:
Comments (0)